Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation
Melanie Vogl, Anna Rosenmayr, T Bohanes, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 658-658
Open Access | Times Cited: 25

Showing 25 citing articles:

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
James Harber, Tamihiro Kamata, Catrin Pritchard, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 9, pp. e003032-e003032
Open Access | Times Cited: 33
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis
Neda Dadgar, Christopher Sherry, Jenna Zimmerman, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas
Nazim Benzerdjeb, Seddig MOMENKHAN, Marie Morfouace, et al.
Research Square (Research Square) (2025)
Closed Access
Mechanisms and shapes of causal exposure-response functions for asbestos in mesotheliomas and lung cancers
Louis Anthony Cox, Kenneth T. Bogen, Rory B. Conolly, et al.
Environmental Research (2023) Vol. 230, pp. 115607-115607
Open Access | Times Cited: 11
The effect of inflammatory scores on the prognosis of malignant mesothelioma
Esma Sevil Akkurt, Ozlem Duvenci Birben, Derya Yenibertiz, et al.
Anatolian Current Medical Journal (2025) Vol. 7, Iss. 1, pp. 67-71
Open Access
The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis
Nadiye Sever, Sedat Yıldırım, Ali Gürbüz, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 144-144
Open Access
Haptoglobin phenotype: A germline risk factor for malignant pleural mesothelioma? A case-control study
Kevin Lamote, Sigurd Delanghe, Marijn M. Speeckaert, et al.
Clinica Chimica Acta (2025) Vol. 573, pp. 120309-120309
Closed Access
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Fatéméh Dubois, Céline Bazille, Jérôme Levallet, et al.
Targeted Oncology (2022) Vol. 17, Iss. 4, pp. 407-431
Open Access | Times Cited: 11
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model
Sabrina Borchert, Alexander Mathilakathu, A. V. B. Nath, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12426-12426
Open Access | Times Cited: 6
Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations
Eugenia Lorenzini, Alessia Ciarrocchi, Federica Torricelli
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2470-2470
Open Access | Times Cited: 15
Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib
Bahil Ghanim, Dina Baier, Christine Pirker, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5602-5602
Open Access | Times Cited: 9
Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma
Sanna Laaksonen, Eeva Kettunen, Eva Sutinen, et al.
Journal of Thoracic Oncology (2022) Vol. 17, Iss. 8, pp. 1032-1041
Closed Access | Times Cited: 8
Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review
Aliakbar Ebrahimi, Güntülü Ak, Ceren Özel, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3299-3333
Open Access | Times Cited: 1
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
Sophie Rovers, Annelies Janssens, Jo Raskin, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 673-673
Open Access | Times Cited: 7
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort
Ruairi James Harwood Conway, Natalie Smith, William A. Cooper, et al.
ERJ Open Research (2023) Vol. 9, Iss. 6, pp. 00467-2023
Open Access | Times Cited: 3
LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential
Xiaoling Xu, Huihui Li, Mingying Xie, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 104012-104012
Closed Access | Times Cited: 3
Malignant Mesothelioma
Daniel Pouliquen, Joanna Kopecka
Cancers (2021) Vol. 13, Iss. 14, pp. 3447-3447
Open Access | Times Cited: 7
Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma
Senar Ebinç, Zeynep Oruç, Ziya Kalkan, et al.
Turkish Journal of Thoracic and Cardiovascular Surgery (2023) Vol. 31, Iss. 1, pp. 105-115
Open Access | Times Cited: 2
Serum Expression Levels of Certain miRNAs in Predicting Diagnosis, Prognosis, and Response to Chemotherapy in Malignant Pleural Mesothelioma
Muzaffer Metintaş, Güntülü Ak, Cansu Özbayer, et al.
Balkan Medical Journal (2022) Vol. 39, Iss. 4, pp. 246-254
Open Access | Times Cited: 4
Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural Mesothelioma
Eleonora Faccioli, Stefano Terzi, Chiara Giraudo, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3699-3699
Open Access | Times Cited: 4
Ki67 Tumor Expression Predicts Treatment Benefit Achieved by Macroscopic Radical Lung-Preserving Surgery in Pleural Mesothelioma—A Retrospective Multicenter Analysis
Sarah Hintermair, Stephanie Iser, Alexander Varga, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1817-1817
Open Access
Prognostic significance of inflammation-related and electrolyte laboratory variables in patients with malignant pleural mesothelioma
Yuan Zhang, Jie Li, Shu Zhang
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 1
Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma
Stephanie Iser, Sarah Hintermair, Alexander Varga, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 93-93
Open Access | Times Cited: 1
Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma
Yuan Zhang, Ran Li, Yumei Gu, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1874-1874
Open Access | Times Cited: 2
[Research Progress of Immune Checkpoint Inhibitors 
in Malignant Pleural Mesothelioma].
Yaru Huang, Qingwei Meng
DOAJ (DOAJ: Directory of Open Access Journals) (2021) Vol. 24, Iss. 6, pp. 441-446
Closed Access | Times Cited: 1
Page 1

Scroll to top